Brown NJ - Search Results

1

Contribution of endogenous bradykinin to fibrinolysis, inflammation, and blood product transfusion following cardiac surgery: a randomized clinical trial.

Balaguer JM, Yu C, Byrne JG, Ball SK, Petracek MR, Brown NJ, Pretorius M. Balaguer JM, et al. Among authors: brown nj. Clin Pharmacol Ther. 2013 Apr;93(4):326-34. doi: 10.1038/clpt.2012.249. Epub 2012 Dec 24. Clin Pharmacol Ther. 2013. PMID: 23361105 Free PMC article. Clinical Trial.

2

Caffeine potentiates the renin response to diazoxide in man. Evidence for a regulatory role of endogenous adenosine.

Brown NJ, Porter J, Ryder D, Branch RA. Brown NJ, et al. J Pharmacol Exp Ther. 1991 Jan;256(1):56-61. J Pharmacol Exp Ther. 1991. PMID: 1988669 Clinical Trial.

3

Differential effects of angiotensin converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykinin.

Brown NJ, Ryder D, Gainer JV, Morrow JD, Nadeau J. Brown NJ, et al. J Pharmacol Exp Ther. 1996 Nov;279(2):703-12. J Pharmacol Exp Ther. 1996. PMID: 8930174 Clinical Trial.

4

ACE insertion/deletion genotype affects bradykinin metabolism.

Brown NJ, Blais C Jr, Gandhi SK, Adam A. Brown NJ, et al. J Cardiovasc Pharmacol. 1998 Sep;32(3):373-7. doi: 10.1097/00005344-199809000-00006. J Cardiovasc Pharmacol. 1998. PMID: 9733349

5

Inhibition of aminopeptidase P potentiates wheal response to bradykinin in angiotensin-converting enzyme inhibitor-treated humans.

Kim KS, Kumar S, Simmons WH, Brown NJ. Kim KS, et al. Among authors: brown nj. J Pharmacol Exp Ther. 2000 Jan;292(1):295-8. J Pharmacol Exp Ther. 2000. PMID: 10604961

6

Metabolism of bradykinin In vivo in humans: identification of BK1-5 as a stable plasma peptide metabolite.

Murphey LJ, Hachey DL, Oates JA, Morrow JD, Brown NJ. Murphey LJ, et al. Among authors: brown nj. J Pharmacol Exp Ther. 2000 Jul;294(1):263-9. J Pharmacol Exp Ther. 2000. PMID: 10871321

7

Endogenous bradykinin and the renin and pressor responses to furosemide in humans.

Murphey LJ, Kumar S, Brown NJ. Murphey LJ, et al. Among authors: brown nj. J Pharmacol Exp Ther. 2000 Nov;295(2):644-8. J Pharmacol Exp Ther. 2000. PMID: 11046100 Clinical Trial.

8

Smoking impairs bradykinin-stimulated t-PA release.

Pretorius M, Rosenbaum DA, Lefebvre J, Vaughan DE, Brown NJ. Pretorius M, et al. Among authors: brown nj. Hypertension. 2002 Mar 1;39(3):767-71. doi: 10.1161/hy0302.105767. Hypertension. 2002. PMID: 11897760 Clinical Trial.

9

Ethnicity affects vasodilation, but not endothelial tissue plasminogen activator release, in response to bradykinin.

Rosenbaum DA, Pretorius M, Gainer JV, Byrne D, Murphey LJ, Painter CA, Vaughan DE, Brown NJ. Rosenbaum DA, et al. Among authors: brown nj. Arterioscler Thromb Vasc Biol. 2002 Jun 1;22(6):1023-8. doi: 10.1161/01.atv.0000017704.45007.1d. Arterioscler Thromb Vasc Biol. 2002. PMID: 12067915

10

Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin.

Pretorius M, Rosenbaum D, Vaughan DE, Brown NJ. Pretorius M, et al. Among authors: brown nj. Circulation. 2003 Feb 4;107(4):579-85. doi: 10.1161/01.cir.0000046268.59922.a4. Circulation. 2003. PMID: 12566370 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

865 results

Search Page

Filters